Opioid antagonist

Results: 102



#Item
31SAMHSA Opioid Overdose Toolkit: Information for Prescribers

SAMHSA Opioid Overdose Toolkit: Information for Prescribers

Add to Reading List

Source URL: www.maine.gov

Language: English - Date: 2014-12-23 13:04:46
32SIB-Clinical Perspectives Pharmacological Approaches Caron Byrne BA MSC MD Psychiatrist Eric Bontogon RPN BA Psych. Nurse October 2014

SIB-Clinical Perspectives Pharmacological Approaches Caron Byrne BA MSC MD Psychiatrist Eric Bontogon RPN BA Psych. Nurse October 2014

Add to Reading List

Source URL: www.interprofessional.ubc.ca

Language: English - Date: 2014-10-27 17:44:05
33SIB-Clinical Perspectives Pharmacological Approaches Caron Byrne BA MSC MD Psychiatrist Eric Bontogon RPN BA Psych. Nurse October 2014

SIB-Clinical Perspectives Pharmacological Approaches Caron Byrne BA MSC MD Psychiatrist Eric Bontogon RPN BA Psych. Nurse October 2014

Add to Reading List

Source URL: interprofessional.ubc.ca

Language: English - Date: 2014-10-27 17:44:05
34Microsoft Word - POATS Naltrexone Fact Sheet_2012-03-17

Microsoft Word - POATS Naltrexone Fact Sheet_2012-03-17

Add to Reading List

Source URL: attcnetwork.org

Language: English - Date: 2014-05-30 15:47:02
35Decision Support Tool (DST) for the use of naloxone HCl (Narcan) in the management of suspected opioid overdose in outreach and harm reduction settings Introduction Opioid overdose that is not detected or treated in a ti

Decision Support Tool (DST) for the use of naloxone HCl (Narcan) in the management of suspected opioid overdose in outreach and harm reduction settings Introduction Opioid overdose that is not detected or treated in a ti

Add to Reading List

Source URL: towardtheheart.com

Language: English - Date: 2014-11-21 20:00:31
36Kappa Opioid Receptor Agonists and Antagonist Summary: The present invention is an entirely new chemotype of KOR weak partial agonists. Contact Information: Matt Koenig, J.D. KU Innovation & Collaboration[removed]m

Kappa Opioid Receptor Agonists and Antagonist Summary: The present invention is an entirely new chemotype of KOR weak partial agonists. Contact Information: Matt Koenig, J.D. KU Innovation & Collaboration[removed]m

Add to Reading List

Source URL: kuic.ku.edu

Language: English - Date: 2014-01-30 10:26:50
37Novel Methods for Antagonizing Kappa Opioid Receptors Summary: The invention is a method for antagonizing kappa opioid receptors (KOR) present in tissue in vitro or in vivo. Contact Information: Aswini K. Betha, Ph.D. KU

Novel Methods for Antagonizing Kappa Opioid Receptors Summary: The invention is a method for antagonizing kappa opioid receptors (KOR) present in tissue in vitro or in vivo. Contact Information: Aswini K. Betha, Ph.D. KU

Add to Reading List

Source URL: kuic.ku.edu

Language: English - Date: 2014-01-30 10:23:55
38TAKE HOME NALOXONE: KEY POINTS FOR MEDICAL, ETHICAL AND LEGAL CONCERNS Naloxone is a medication that saves lives by reversing the effects of an overdose from opioids (e.g. heroin, methadone, morphine). BC’s Take Home N

TAKE HOME NALOXONE: KEY POINTS FOR MEDICAL, ETHICAL AND LEGAL CONCERNS Naloxone is a medication that saves lives by reversing the effects of an overdose from opioids (e.g. heroin, methadone, morphine). BC’s Take Home N

Add to Reading List

Source URL: towardtheheart.com

Language: English - Date: 2014-11-21 20:00:26
39Collaborative Drug Therapy Agreement for Naloxone Medication in Overdose Prevention

Collaborative Drug Therapy Agreement for Naloxone Medication in Overdose Prevention

Add to Reading List

Source URL: stopoverdose.org

Language: English - Date: 2013-01-22 18:40:45
40Special Issue: Call for Papers Editor-in-Chief: Adam J. Gordon, MD MPH FACP FASAM In cooperation with Deadlines

Special Issue: Call for Papers Editor-in-Chief: Adam J. Gordon, MD MPH FACP FASAM In cooperation with Deadlines

Add to Reading List

Source URL: www.integration.samhsa.gov

Language: English